How long does it take for Donanemab to take effect after treatment?

Donanemab (Donanemab) is a monoclonal antibody targeting β-amyloid protein. It is mainly used to treat early Alzheimer's disease (AD). It helps slow the decline of cognitive function by clearing beta-amyloid plaques from the brain. Many patients and family members are concerned about how long it will take to see obvious therapeutic effects after taking donenezumab, which is very important for rationally arranging treatment and adjusting expectations.

Clinical trial data show that within the first three months after treatment with donenezumab, the patient's brain β- amyloid load began to significantly reduce, which is the biological basis for its effect. However, improvements in cognitive function often take longer to show. Most patients begin to experience slight cognitive and functional improvements around 6 months after taking the drug. This stage is mainly characterized by the stabilization of memory and daily living abilities.

As treatment continues, the effects of donenezumab accumulate. During the treatment cycle of approximately 12 months or more, some patients show a more significant slowdown in cognitive function or even a certain degree of improvement. It is worth noting that there are individual differences in the effects of drugs. Some patients may respond quickly, while others may take longer to observe significant changes.

In general, treatment with donenezumab requires a certain amount of time to accumulate, and immediate effects should not be expected in the short term. Patients and family members should remain patient, cooperate with doctors to regularly evaluate treatment response, and pay attention to possible side effects of drugs. Long-term adherence to treatment is the key to achieving optimal curative effects and is also an important guarantee for improving the quality of life of patients with Alzheimer's disease.

Reference materials:https://www.drugs.com